WASHINGTON, D.C. - AdvaMed President and CEO Stephen J. Ubl released the following statement regarding an announcement by China’s Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) and the inspection of U.S. manufactured medical devices:
